BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31642963)

  • 1. Can [
    Elekonawo FMK; Starremans B; Laurens ST; Bremers AJA; de Wilt JHW; Heijmen L; de Geus-Oei LF
    Abdom Radiol (NY); 2020 Feb; 45(2):301-306. PubMed ID: 31642963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Value of (18)F-FDG- PET-CT in the Preoperative Staging of Peritoneal Carcinomatosis from Colorectal Origin.
    De Vos N; Goethals I; Ceelen W
    Acta Chir Belg; 2014; 114(6):370-5. PubMed ID: 26021680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of (18)F-FDG PET/CT in the preoperative evaluation of patients diagnosed with peritoneal carcinomatosis of ovarian origin, candidates to cytoreduction and hipec. A pending issue.
    Lopez-Lopez V; Cascales-Campos PA; Gil J; Frutos L; Andrade RJ; Fuster-Quiñonero M; Feliciangeli E; Gil E; Parrilla P
    Eur J Radiol; 2016 Oct; 85(10):1824-1828. PubMed ID: 27666623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of FDG-PET/CT in Colorectal Peritoneal Carcinomatosis: Potential Tool for Evaluation of Chemotherapeutic Response.
    Liberale G; Lecocq C; Garcia C; Muylle K; Covas A; Deleporte A; Hendlisz A; Bouazza F; El Nakadi I; Flamen P
    Anticancer Res; 2017 Feb; 37(2):929-934. PubMed ID: 28179354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of contrast-enhanced CT combined with 18-FDG PET in patients selected for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Sommariva A; Evangelista L; Pintacuda G; Cervino AR; Ramondo G; Rossi CR
    Abdom Radiol (NY); 2018 May; 43(5):1094-1100. PubMed ID: 28770289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (18)F-FDG PET/CT, cytoreductive surgery and intraperitoneal chemohyperthermia for the therapeutic management in peritoneal carcinomatosis: A pilot study.
    Cistaro A; Cucinotta M; Cassalia L; Priola A; Priola S; Pappalardo M; Coppolino P; De Simone M; Quartuccio N
    Rev Esp Med Nucl Imagen Mol; 2016; 35(4):232-7. PubMed ID: 26907833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pitfalls and mimickers on (18)F-FDG-PET/CT in peritoneal carcinomatosis from colorectal cancer: An analysis from 37 patients.
    Audollent R; Eveno C; Dohan A; Sarda L; Jouvin I; Soyer P; Pocard M
    J Visc Surg; 2015 Nov; 152(5):285-91. PubMed ID: 26115889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (18)F-FDG-PET/CT to select patients with peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Pfannenberg C; Königsrainer I; Aschoff P; Oksüz MO; Zieker D; Beckert S; Symons S; Nieselt K; Glatzle J; Weyhern CV; Brücher BL; Claussen CD; Königsrainer A
    Ann Surg Oncol; 2009 May; 16(5):1295-303. PubMed ID: 19252950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-body diffusion-weighted MRI for operability assessment in patients with colorectal cancer and peritoneal metastases.
    Dresen RC; De Vuysere S; De Keyzer F; Van Cutsem E; Prenen H; Vanslembrouck R; De Hertogh G; Wolthuis A; D'Hoore A; Vandecaveye V
    Cancer Imaging; 2019 Jan; 19(1):1. PubMed ID: 30616608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of relapse in patients with peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy using F-18-FDG-PET/CT.
    Klumpp B; Schwenzer NF; Gatidis S; Koenigsrainer I; Koenigsrainer A; Beckert S; Mueller M; Claussen CD; Pfannenberg C
    Rofo; 2014 Apr; 186(4):359-66. PubMed ID: 24683168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative CT-based predictive factors for resectability and medium-term overall survival in patients with peritoneal carcinomatosis from colorectal cancer.
    Suzuki C; Wallgren H; Abraham-Nordling M; Palmer G
    Clin Radiol; 2018 Aug; 73(8):756.e11-756.e16. PubMed ID: 29678273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are positron emission tomography-computed tomography (PET-CT) scans useful in preoperative assessment of patients with peritoneal disease before cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)?
    Wang W; Tan GHC; Chia CS; Skanthakumar T; Soo KC; Teo MCC
    Int J Hyperthermia; 2018 Aug; 34(5):524-531. PubMed ID: 28854825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Staging of peritoneal carcinomatosis: enhanced CT vs. PET/CT.
    Dromain C; Leboulleux S; Auperin A; Goere D; Malka D; Lumbroso J; Schumberger M; Sigal R; Elias D
    Abdom Imaging; 2008; 33(1):87-93. PubMed ID: 17632751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution Characteristics of Colorectal Peritoneal Carcinomatosis Based on the Positron Emission Tomography/Peritoneal Cancer Index.
    Sun CF; Tan ZH; Shen C; Mao XY; Ge CC; Gao Y; Hu CH
    Cancer Biother Radiopharm; 2022 Sep; 37(7):517-526. PubMed ID: 32833546
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of [
    Zhao L; Pang Y; Luo Z; Fu K; Yang T; Zhao L; Sun L; Wu H; Lin Q; Chen H
    Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1944-1955. PubMed ID: 33415432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative computed tomography and selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    de Bree E; Koops W; Kröger R; van Ruth S; Verwaal VJ; Zoetmulder FA
    Eur J Surg Oncol; 2006 Feb; 32(1):65-71. PubMed ID: 16290055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of peritoneal carcinomatosis extent diagnosis by initial FDG PET CT in epithelial ovarian cancer: A multicentre study of the FRANCOGYN research group.
    Delvallée J; Rossard L; Bendifallah S; Touboul C; Collinet P; Bricou A; Huchon C; Lavoue V; Body G; Ouldamer L
    J Gynecol Obstet Hum Reprod; 2020 Nov; 49(9):101867. PubMed ID: 32663654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of recurrence in gastric carcinoma: Comparison of contrast-enhanced computed tomography and positron emission tomography/computed tomography.
    Kim JH; Heo SH; Kim JW; Shin SS; Min JJ; Kwon SY; Jeong YY; Kang HK
    World J Gastroenterol; 2017 Sep; 23(35):6448-6456. PubMed ID: 29085194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is unexpected peritoneal carcinomatosis still a contraindication for resection of colorectal liver metastases? Combined resection of colorectal liver metastases with peritoneal deposits discovered intra-operatively.
    Allard MA; Adam R; Ruiz A; Vibert E; Paule B; Levi F; Sebagh M; Guettier C; Azoulay D; Castaing D
    Eur J Surg Oncol; 2013 Sep; 39(9):981-7. PubMed ID: 23845705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative assessment of peritoneal carcinomatosis in patients undergoing hyperthermic intraperitoneal chemotherapy following cytoreductive surgery.
    Pasqual EM; Bertozzi S; Bacchetti S; Londero AP; Basso SM; Santeufemia DA; Lo Re G; Lumachi F
    Anticancer Res; 2014 May; 34(5):2363-8. PubMed ID: 24778044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.